Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma

2.1 Chlormethine gel (Ledaga, Recordati Rare Diseases and Helsinn Healthcare) is indicated for 'the topical treatment of mycosis fungoides-type cutaneous T‑cell lymphoma (MF‑type CTCL) in adult patients'.

2.2 The dosage schedule is available in the summary of product characteristics.

2.3 The list price for chlormethine gel is £1,000 per 60 g tube (excluding VAT; BNF online accessed 17 July 2020).

2.4 The company has a commercial arrangement. This makes chlormethine gel available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.